Tools to Guide Treatment Decisions in Breast Cancer

home / insights / tools-to-guide-treatment-decisions-in-breast-cancer

Mark Pegram, MD, and Lee Schwartzberg, MD, FACP, have a discussion on the management of early-stage hormone-receptor-positive breast cancer and the tools available to help inform treatment decisions.

The Evolution of Early-Stage HR+ Breast Cancer Management

EP. 1: The Evolution of Early-Stage HR+ Breast Cancer Management

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
August 5th 2022
Measuring Ki-67 Levels to Inform HR+ Breast Cancer Treatment

EP. 2: Measuring Ki-67 Levels to Inform HR+ Breast Cancer Treatment

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
August 5th 2022
Updated Guidelines for the Management of HR+ Breast Cancer

EP. 3: Updated Guidelines for the Management of HR+ Breast Cancer

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
August 12th 2022
Recurrence Patterns in Early-Stage HR+ Breast Cancer

EP. 4: Recurrence Patterns in Early-Stage HR+ Breast Cancer

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
August 12th 2022
Tools to Guide Treatment Decision-Making in HR+ Breast Cancer

EP. 5: Tools to Guide Treatment Decision-Making in HR+ Breast Cancer

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
August 19th 2022
Ordering Additional Multigene Assays for Patients with HR+ Breast Cancer

EP. 6: Ordering Additional Multigene Assays for Patients with HR+ Breast Cancer

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
August 19th 2022
Data on Extended Adjuvant Endocrine Therapy in HR+ Breast Cancer

EP. 7: Data on Extended Adjuvant Endocrine Therapy in HR+ Breast Cancer

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
August 26th 2022
Biomarkers for Selection of Extended Endocrine Therapy in HR+ Breast Cancer

EP. 8: Biomarkers for Selection of Extended Endocrine Therapy in HR+ Breast Cancer

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
August 26th 2022
Clinical and Practical Implications of the Breast Cancer Index

EP. 9: Clinical and Practical Implications of the Breast Cancer Index

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
September 7th 2022
Future Directions in HR+ Breast Cancer Management

EP. 10: Future Directions in HR+ Breast Cancer Management

Mark D. Pegram, MD;Lee S. Schwartzberg, MD, FACP
September 7th 2022